0001415889-22-001749.txt : 20220223 0001415889-22-001749.hdr.sgml : 20220223 20220223203633 ACCESSION NUMBER: 0001415889-22-001749 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220218 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wellisch Alejandro D CENTRAL INDEX KEY: 0001717526 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 22666006 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-02232022_050209.xml X0306 4 2022-02-18 0000001800 ABBOTT LABORATORIES ABT 0001717526 Wellisch Alejandro D 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false SENIOR VICE PRESIDENT Option (right to buy) 117.58 2022-02-18 4 A 0 54280 0 A 2023-02-18 2032-02-17 Common Shares 54280 54280 D Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 18,093 on February 18, 2023, 18,093 on February 18, 2024, and 18,094 on February 18, 2025. /s/ Alejandro D. Wellisch by Jessica H. Paik, Attorney-in-Fact 2022-02-23